Allarity Therapeutics

(NASDAQ) ALLR

Current Price$1.61

Market Cap$25.62M

Since IPO (2021)-100%

5 Year-100%

1 Year+101%

1 Month+9%

Allarity Therapeutics Financials at a Glance

Market Cap

$25.62M

Revenue (TTM)

$345.00K

Net Income (TTM)

-$11.25M

EPS (TTM)

-$0.72

P/E Ratio

-2.23

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$1.61

Volume

157,000

Open

$1.71

Price

$1.61

Volume

157,000

Open

$1.71

Previous Close

$1.61

Daily Range

$1.56 - $1.72

52-Week Range

$0.77 - $2.35

Estimated Earnings Date

Aug 21, 2026

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$1.61

Volume

157,000

Open

$1.71

Previous Close

$1.61

Daily Range

$1.56 - $1.72

52-Week Range

$0.77 - $2.35

Estimated Earnings Date

Aug 21, 2026

ALLR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Allarity Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Thomas H. Jensen

Website

www.allarity.com

Headquarters

Boston, MA 02139, US

ALLR Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-36%

Net Income Margin

-33%

Return on Equity

-88%

Return on Capital

-2%

Return on Assets

-32%

Earnings Yield

-44.84%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.62M

Shares Outstanding

15.91M

Volume

157.00K

Avg. Volume

203.81K

Financials (TTM)

Gross Profit

$320.00K

Operating Income

-$12.61M

EBITDA

-$11.05M

Operating Cash Flow

-$14.82M

Capital Expenditure

-$8.00K

Free Cash Flow

-$14.83M

Cash & ST Invst.

$14.69M

Total Debt

$1.40M

Allarity Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$25.00K

N/A

Gross Profit

$51.00K

N/A

Gross Margin

2.04%

N/A

Market Cap

$25.62M

N/A

Market Cap/Employee

$4.27M

N/A

Employees

N/A

Net Income

-$2.75M

-0.7%

EBITDA

-$2.71M

-1.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$1.68M

-107.1%

Accounts Receivable

$1.08M

-3.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$21.50M

+1477.1%

Return on Assets

-32.21%

N/A

Return on Invested Capital

-1.77%

N/A

Free Cash Flow

-$4.56M

-69.7%

Operating Cash Flow

-$4.49M

-67.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CINGCingulate Inc.

CINGCingulate Inc.$4.50-6.35%

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

CRISCuris, Inc.

CRISCuris, Inc.$0.47-5.34%

BCTXBriaCell Therapeutics Corp.

BCTXBriaCell Therapeutics Corp.$3.08-5.52%

PCSAProcessa Pharmaceuticals, Inc.

PCSAProcessa Pharmaceuticals, Inc.$2.52-8.68%

CASICASI Pharmaceuticals, Inc.

CASICASI Pharmaceuticals, Inc.$0.15+3.08%

CLSDClearside Biomedical, Inc.

CLSDClearside Biomedical, Inc.$0.41+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

INTCIntel

INTCIntel$99.17-0.11%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

Questions About ALLR

What is the current price of Allarity Therapeutics?

Allarity Therapeutics is trading at $1.61 per share.

What is the 52-week range for Allarity Therapeutics?

Over the past 52 weeks, Allarity Therapeutics has traded between $0.77 and $2.35.

How much debt does Allarity Therapeutics have?

As of the most recent reporting period, Allarity Therapeutics reported total debt of $21.50M.

How much cash does Allarity Therapeutics have on hand?

Allarity Therapeutics reported $29.81M in cash and cash equivalents in its most recent financial results.

What is Allarity Therapeutics’s dividend yield?

Allarity Therapeutics does not currently have a dividend yield.

Allarity Therapeutics

Allarity Therapeutics Financials at a Glance

ALLR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Allarity Therapeutics

ALLR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Allarity Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALLR

What is the current price of Allarity Therapeutics?

What is the 52-week range for Allarity Therapeutics?

How much debt does Allarity Therapeutics have?

How much cash does Allarity Therapeutics have on hand?

What is Allarity Therapeutics’s dividend yield?

Premium Investing Services